Icotinib hydrochloride

Icotinib hydrochloride or icotinib HCl, is a first generation inhibitor of tyrosine kinase epidermal growth factor receptor (EGFR-TK) . It has been used in measuring the efficacy of novel anti-cancer compoundsin vivoagainst non-small-cell lung cancers that formed advanced solid tumors. Icotinib reversibly inhibits EGFR-TK competitively by blocking the ATP-binding site on tyrosine kinase.Product SpecificationsIcotinib hydrochlorideIcotinib HClIcotinibFormula: C22H22ClN3O4MW: 427.88 g/mol